Informations sur le produit
Nom:DGAT-1 inhibitor 2
Marque:Biosynth
Description :DGAT-1 inhibitor 2 is an oxadiazole derivative that has been shown to be a potent inhibitor of the DGAT-1 enzyme in humans. This compound has been shown to have a permeability profile in animals that is similar to meglumine, a known DGAT-1 inhibitor. The compound also binds to elements on the surface of cells that are thought to be important for the catalytic activity of DGAT-1 enzymes, and has demonstrated attenuation of obesity and metabolic syndrome in animal models.
DGAT-1 inhibitor 2 is most likely active against obesity by inhibiting the synthesis of triglycerides from glucose in adipose tissue. DGAT-1 inhibitors are also thought to have potential therapeutic applications for diabetes mellitus type II and other conditions associated with insulin resistance.
DGAT-1 inhibitor 2 is most likely active against obesity by inhibiting the synthesis of triglycerides from glucose in adipose tissue. DGAT-1 inhibitors are also thought to have potential therapeutic applications for diabetes mellitus type II and other conditions associated with insulin resistance.
Avis:Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Propriétés chimiques
Masse moléculaire :420.5 g/mol
Formule :C24H28N4O3
Degré de pureté :Min. 95%